Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 14, 2018 - Issue 2
Submit an article Journal homepage
1,669
Views
7
CrossRef citations to date
0
Altmetric
Editorial

ABCB1: is there a role in the drug treatment of Parkinson’s disease?

Thomas MüllerDepartment of Neurology, St. Joseph Hospital Berlin-Weissensee, Berlin, GermanyCorrespondence[email protected] [email protected]
View further author information
Pages 127-129 | Received 01 Oct 2017, Accepted 08 Dec 2017, Published online: 12 Dec 2017

References

  • Vautier S, Milane A, Fernandez C, et al. Interactions between antiparkinsonian drugs and ABCB1/P-glycoprotein at the blood-brain barrier in a rat brain endothelial cell model. Neurosci Lett. 2008;442:19–23.
  • Dutheil F, Jacob A, Dauchy S, et al. ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders. Expert Opin Drug Metab Toxicol. 2010;6:1161–1174.
  • Vautier S, Fernandez C. ABCB1: the role in Parkinson’s disease and pharmacokinetics of antiparkinsonian drugs. Expert Opin Drug Metab Toxicol. 2009;5:1349–1358.
  • Tanner CM, Ross GW, Jewell SA, et al. Occupation and risk of Parkinsonism: a multicenter case-control study. Arch Neurol. 2009;66:1106–1113.
  • Blum-Degen D, Müller T, Kuhn W, et al. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo Parkinson’s disease patients. Neurosci Lett. 1995;202:17–20.
  • Häussermann P, Kuhn W, Przuntek H, et al. Integrity of the blood-cerebrospinal fluid barrier in early Parkinson’s disease. Neurosci Lett. 2001;300:182–184.
  • Bartels AL, Willemsen AT, Kortekaas R, et al. Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA. J Neural Transm (Vienna). 2008;115:1001–1009.
  • Müller T. Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson’s disease. Expert Rev Neurother. 2013;13:707–718.
  • Müller T. Pharmacokinetic drug evaluation of safinamide mesylate for the treatment of mid-to-late stage Parkinson’s disease. Expert Opin Drug Metab Toxicol. 2017;13:693–699.
  • Pingili R, Vemulapalli S, Mullapudi SS, et al. Pharmacokinetic interaction study between flavanones (hesperetin, naringenin) and rasagiline mesylate in wistar rats. Drug Dev Ind Pharm. 2016;42:1110–1117.
  • Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson’s disease in DATATOP patients requiring levodopa. Ann Neurol. 1996;39:37–45.
  • Olanow CW, Rascol O, Hauser R, et al. A double-blind, delayed-start trial of rasagiline in Parkinson’s disease. N Engl J Med. 2009;361:1268–1278.
  • Przuntek H, Conrad B, Dichgans J, et al. SELEDO: a 5-year long-term trial on the effect of selegiline in early Parkinsonian patients treated with levodopa. Eur J Neurol. 1999;6:141–150.
  • Schapira AH, McDermott MP, Barone P, et al. Pramipexole in patients with early Parkinson’s disease (PROUD): a randomised delayed-start trial. Lancet Neurol. 2013;12:747–755.
  • Kim RB. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metabolism Reviews. 2002;34:47–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.